Cerebellar ataxias, a group of disabling and untreatable neurodegenerative disorders affecting up to 150,000 people in the United States, result in uncoordinated limb and trunk movements and falls, frequently leading to wheelchair confinement. At the cellular level, the ataxias are primarily associated with neuronal loss within the cerebellum and its associated pathways. Neuronal dysfunction precedes and accompanies neuronal loss and contributes to motor symptoms, but the mechanisms responsible for these early events are poorly understood. In Spinocerebellar Ataxia type 1 (SCA1), the best studied and one of the more common dominantly inherited ataxias, a reduction in cerebellar Purkinje neuron cell size and dendritic arborization precedes overt neuronal loss, as in other ataxias. Building on our prior work establishing that electrophysiological dysfunction of cerebellar neurons contributes to motor deficits in different mouse models of ataxia, we now seek to determine whether changes in Purkinje neuron function contribute to altered morphology and motor dysfunction in SCA1. Purkinje neurons generate autonomous, pacemaker action potentials even in the absence of synaptic input. Our preliminary data in a mouse model of SCA1 demonstrate that Purkinje neuron pacemaker firing is initially normal, but by 5 weeks of age, pacemaker firing is disrupted, together with abnormal depolarization of membrane potential associated with reduced activity of subthreshold-activated potassium channels. Strikingly, subsequent Purkinje cell shrinkage is associated with relative restoration of pacemaker firing, indicating that cell shrinkage may reflect the attempt of Purkinje neurons to compensate for physiologic dysfunction. We hypothesize that abnormal activity of subthreshold-activated potassium channels is a critical early event in the pathogenesis of SCA1. We also hypothesize that compensatory mechanisms to maintain normal Purkinje pacemaker firing contribute to cell shrinkage - which is actually beneficial - but that failure of this compensation leads to neurodegeneration. In the following specific aims we propose to test these hypotheses at the cell and circuit level, and to explore whether preventing potassium channel dysfunction will ameliorate neurodegeneration and motor dysfunction. The project has three aims.
Aim 1 will determine the mechanism underlying membrane depolarization in SCA1 Purkinje neurons.
Aim 2 will determine the consequences of Purkinje neuron atrophy on cerebellar circuitry, and aim 3 will determine whether maintaining normal membrane potential will prevent Purkinje neuron atrophy and improve motor symptoms in SCA1 transgenic mice.

Public Health Relevance

Spinocerebellar ataxia type 1 (SCA1), the most extensively studied and one of the more common dominantly inherited forms of ataxia, causes loss of balance and coordination in patients and is associated with a loss of nerve cells in certain in the cerebellum and its associated pathways. This proposal examines whether correcting perturbations in the electrical properties of nerve cells in the cerebellum in SCA1 and possibly other degenerative ataxias will lead to the development of new drugs to treat this currently untreatable disorder.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Cellular and Molecular Biology of Neurodegeneration Study Section (CMND)
Program Officer
Gwinn, Katrina
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Medicine
Ann Arbor
United States
Zip Code
Bushart, David D; Chopra, Ravi; Singh, Vikrant et al. (2018) Targeting potassium channels to treat cerebellar ataxia. Ann Clin Transl Neurol 5:297-314
Chopra, Ravi; Wasserman, Aaron H; Pulst, Stefan M et al. (2018) Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia. Hum Mol Genet 27:1396-1410
Chopra, Ravi; Bushart, David D; Shakkottai, Vikram G (2018) Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1. PLoS One 13:e0198040
McLoughlin, Hayley S; Moore, Lauren R; Chopra, Ravi et al. (2018) Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. Ann Neurol 84:64-77
Shakkottai, Vikram G; Batla, Amit; Bhatia, Kailash et al. (2017) Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia. Cerebellum 16:577-594
Dell'Orco, James M; Pulst, Stefan M; Shakkottai, Vikram G (2017) Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2. Hum Mol Genet 26:3935-3945
Bushart, David D; Murphy, Geoffrey G; Shakkottai, Vikram G (2016) Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease. Ann Transl Med 4:25
Lo, Raymond Y; Figueroa, Karla P; Pulst, Stefan M et al. (2016) Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord 22:87-92
Chung, Chan; Elrick, Matthew J; Dell'Orco, James M et al. (2016) Heat Shock Protein Beta-1 Modifies Anterior to Posterior Purkinje Cell Vulnerability in a Mouse Model of Niemann-Pick Type C Disease. PLoS Genet 12:e1006042
Jones, Julie M; Dionne, Louise; Dell'Orco, James et al. (2016) Single amino acid deletion in transmembrane segment D4S6 of sodium channel Scn8a (Nav1.6) in a mouse mutant with a chronic movement disorder. Neurobiol Dis 89:36-45

Showing the most recent 10 out of 18 publications